Abstract:1. The effects of a transdermal clonidine delivery system (M-5041T) on EEG sleep pattern with relation to plasma concentrations in unrestrained rabbits were investigated and compared with those of intravenous (i.v.) administration of clonidine. 2. Although M-5041T did not affect the EEG recorded from cortex and hippocampus at doses up to 2.5 mg/kg, slow theta waves in hippocampal EEG accompanied by low-voltage slow waves in cortex were induced at a higher dose of 12.5 mg/kg. On i.v. injection (0.25 mg/kg), EEG tracings with bursts of high-voltage slow waves in cortical EEG and slow theta waves in hippocampus were observed. 3. At doses of 0.5 and 2.5 mg/kg, M-5041T did not cause any alterations of the sleep-wake cycle, and plasma concentrations of 1-2 ng/ml were maintained for an 8-hr observation period. However, this delivery system significantly suppressed the incidence of rapid-eye movement sleep (REMS) from 11.9 to 4.7% and enhanced drowsiness (DW) from 9.0 to 21.0% during the 8-hr recording period at 12.5 mg/kg with a plasma concentration of up to 10 ng/ml. Contrary to transdermal administration, i.v. clonidine (0.25 mg/kg) completely blocked light and deep slow wave sleep as well as REMS with a plasma concentration indicated more than 10 ng/ml at 2 hr post administration. Recovery to a normal sleep-wake cycle was eventually established thereafter. The incidence of REMS and DW were significantly decreased from 11.9 to 6.3% and increased from 9.0 to 25.5%, respectively. 4. Concurrent monitoring of clonidine concentrations in cerebrospinal fluid (CSF) indicated that CSF concentrations after patching M-5041T, as well as i.v. clonidine, were almost equal to plasma levels. 5. These results suggest that alteration of the sleep-wake cycle with clonidine occurs depending upon brain concentrations, which increase to a level similar to that in plasma after administration, and that M-5041T at doses of less than 2.5 mg/kg could establish effective hypertensive therapy without obvious effects on the cycle.

Clonidine-induced Changes in the Spectral Distribution of Heart Rate Variability Correlate with Performance on a Test of Sustained Attention

Clonidine and Diazepam Have Differential-Effects on Tests of Attention and Learning

Differential Effects of Clonidine, Haloperidol, Diazepam and Tryptophan Depletion on Focused Attention and Attentional Search

Central noradrenergic responsiveness to a clonidine challenge in Generalized Anxiety Disorder: a Single Photon Emission Computed Tomography study

Effects of chronic clonidine administration on sympathetic nerve traffic and baroreflex function in heart failure

Idazoxan Potentiates Rather Than Antagonizes Some of the Cognitive Effects of Clonidine

Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats

Features of α2-Adrenergic Regulation of Isolated Rat Heart after Hypokinesia

Effects of transdermal clonidine in young and elderly patients with mild hypertension: evaluation by three noninvasive methods of blood pressure measurement

Effects of a newly developed transdermal clonidine delivery system (M-5041T) on EEG sleep-wake cycle in relation to plasma concentration in rabbits

Noradrenergic Effects on Neuronal Activity Related to a Visual Discrimination Task with GO/NO-GO Performances

Contrasting Effects of Clonidine and Diazepam on Tests of Working Memory and Planning

Effect of Clonidine on Heart Rate Variability During Laparoscopic Cholecystectomy

Alpha-2 Adrenergic Modulation of Prefrontal Cortical Neuronal Activity Related to Spatial Working Memory in Monkeys

[Changes in Plasma Neuropeptides Before and after Clonidine in Patients with Essential Hypertension].

When your heart isn't in it anymore: Cardiac correlates of task disengagement

Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure

New indices in the evaluation of clonidine transdermal therapy of hypertension

Contrasts Between the Cardiovascular Concomitants of Tests of Planning and Attention

Hemodynamic and metabolic effects of transdermal clonidine in patients with hypertension and non-insulin-dependent diabetes mellitus

Clonidine Improved Laboratory-Measured Decision-Making Performance in Abstinent Heroin Addicts